245 related articles for article (PubMed ID: 30300141)
41. Identification of Immune Effectors Essential to the Control of Primary and Secondary Intranasal Infection with Brucella melitensis in Mice.
Hanot Mambres D; Machelart A; Potemberg G; De Trez C; Ryffel B; Letesson JJ; Muraille E
J Immunol; 2016 May; 196(9):3780-93. PubMed ID: 27036913
[TBL] [Abstract][Full Text] [Related]
42. Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families.
Yado S; Luboshits G; Hazan O; Or R; Firer MA
J Immunother Cancer; 2019 Nov; 7(1):301. PubMed ID: 31727148
[TBL] [Abstract][Full Text] [Related]
43. Immunosuppressive effects of multiple myeloma are overcome by PD-L1 blockade.
Hallett WH; Jing W; Drobyski WR; Johnson BD
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1133-45. PubMed ID: 21536144
[TBL] [Abstract][Full Text] [Related]
44. Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation.
Keil F; Kalhs P; Chen X; Haas OA; Fritsch G; Chott A; Lechner K; Moser K; Ackermann J; Rabitsch W; Worel N; Mannhalter C; Greinix HT
Ann Hematol; 1999 Aug; 78(8):376-9. PubMed ID: 10460352
[TBL] [Abstract][Full Text] [Related]
45. Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma.
Drent E; Groen RW; Noort WA; Themeli M; Lammerts van Bueren JJ; Parren PW; Kuball J; Sebestyen Z; Yuan H; de Bruijn J; van de Donk NW; Martens AC; Lokhorst HM; Mutis T
Haematologica; 2016 May; 101(5):616-25. PubMed ID: 26858358
[TBL] [Abstract][Full Text] [Related]
46. Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma.
Prabhala RH; Pelluru D; Fulciniti M; Prabhala HK; Nanjappa P; Song W; Pai C; Amin S; Tai YT; Richardson PG; Ghobrial IM; Treon SP; Daley JF; Anderson KC; Kutok JL; Munshi NC
Blood; 2010 Jul; 115(26):5385-92. PubMed ID: 20395418
[TBL] [Abstract][Full Text] [Related]
47. Long-term suppression of tumor growth by TNF requires a Stat1- and IFN regulatory factor 1-dependent IFN-gamma pathway but not IL-12 or IL-18.
Wu TH; Pabin CN; Qin Z; Blankenstein T; Philip M; Dignam J; Schreiber K; Schreiber H
J Immunol; 2004 Mar; 172(5):3243-51. PubMed ID: 14978132
[TBL] [Abstract][Full Text] [Related]
48. CD8(+), alphabeta-TCR(+), and gammadelta-TCR(+) cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow.
Xu H; Exner BG; Cramer DE; Tanner MK; Mueller YM; Ildstad ST
J Immunol; 2002 Feb; 168(4):1636-43. PubMed ID: 11823491
[TBL] [Abstract][Full Text] [Related]
49. Frontline Science: Late CD27 stimulation promotes IL-7Rα transcriptional re-expression and memory T cell qualities in effector CD8
Dong H; Buckner A; Prince J; Bullock T
J Leukoc Biol; 2019 Nov; 106(5):1007-1019. PubMed ID: 31199542
[TBL] [Abstract][Full Text] [Related]
50. Survivin-peptide vaccination elicits immune response after allogeneic nonmyeloablative transplantation: a safe strategy to enhance the graft versus tumor effect.
Circosta P; Vitaggio K; Elia AR; Todorovic M; Sangiolo D; Carnevale-Schianca F; Vallario A; Geuna M; Aglietta M; Cignetti A
Immunotherapy; 2018 Jul; 10(9):753-767. PubMed ID: 30008257
[TBL] [Abstract][Full Text] [Related]
51. Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma.
Hong S; Lee H; Jung K; Lee SM; Lee SJ; Jun HJ; Kim Y; Song H; Bogen B; Choi I
Immunol Lett; 2013; 156(1-2):132-9. PubMed ID: 24148970
[TBL] [Abstract][Full Text] [Related]
52. Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma.
Neelapu SS; Munshi NC; Jagannath S; Watson TM; Pennington R; Reynolds C; Barlogie B; Kwak LW
Bone Marrow Transplant; 2005 Aug; 36(4):315-23. PubMed ID: 15968284
[TBL] [Abstract][Full Text] [Related]
53. CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype.
Zhu Y; Zhu G; Luo L; Flies AS; Chen L
Blood; 2007 Jun; 109(11):4882-9. PubMed ID: 17244673
[TBL] [Abstract][Full Text] [Related]
54. Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell-engrafted NOD/SCID/IL-2Rγc null mice.
Thomas S; Klobuch S; Sommer M; van Ewijk R; Theobald M; Meyer RG; Herr W
Exp Hematol; 2014 Jan; 42(1):28-38.e1-2. PubMed ID: 24120693
[TBL] [Abstract][Full Text] [Related]
55. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
56. A role for IFN-gamma from antigen-specific CD8+ T cells in protective immunity to Listeria monocytogenes.
Messingham KA; Badovinac VP; Jabbari A; Harty JT
J Immunol; 2007 Aug; 179(4):2457-66. PubMed ID: 17675507
[TBL] [Abstract][Full Text] [Related]
57. CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent.
Lee SJ; Rossi RJ; Lee SK; Croft M; Kwon BS; Mittler RS; Vella AT
J Immunol; 2007 Aug; 179(4):2203-14. PubMed ID: 17675480
[TBL] [Abstract][Full Text] [Related]
58. Vitamin C treatment of mouse bone marrow-derived dendritic cells enhanced CD8(+) memory T cell production capacity of these cells in vivo.
Jeong YJ; Kim JH; Hong JM; Kang JS; Kim HR; Lee WJ; Hwang YI
Immunobiology; 2014 Jul; 219(7):554-64. PubMed ID: 24698552
[TBL] [Abstract][Full Text] [Related]
59. Autologous graft versus myeloma: it's not a myth.
Dong S; Ghobrial IM
J Clin Invest; 2019 Jan; 129(1):48-50. PubMed ID: 30457981
[TBL] [Abstract][Full Text] [Related]
60. Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells.
Komatsu H; Kogawa K; Nonoyama S; Inui A; Sogo T; Fujisawa T; Klenerman P
J Med Virol; 2006 Dec; 78(12):1616-23. PubMed ID: 17063516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
